《盈警》泰凌医药(01011.HK)料去年首十月亏损收窄至介乎3,500万元至3,700万元人币

阿斯达克财经
08 Jan

泰凌医药(01011.HK) 公布,预期截至去年10月底止,首十个月将录得亏损净额介乎3,500万元至3,700万元人民币(下同),而2023年同期则录得亏损净额约1.53亿元。

过往派息
公布日期派息事项派息内容
2024/08/30中期业绩无派息
2024/05/14特别业绩合并:10股合并为1股
2024/03/28末期业绩无派息
2023/08/31中期业绩无派息

公司指,亏损减少主要因为公司期内没有录得生产及销售中成药业务亏损,以及集团于2023年期间就两名顾问支付的一次性顾问费用3,770万元,而集团于去年并没有支付任何顾问费用。(vc/u)

(港股报价延迟最少十五分钟。)
AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10